Voyageur Pharmaceuticals' market value is the price at which a share of Voyageur Pharmaceuticals trades on a public exchange. It measures the collective expectations of Voyageur Pharmaceuticals investors about its performance. Voyageur Pharmaceuticals is trading at 0.1 as of the 27th of December 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.1. With this module, you can estimate the performance of a buy and hold strategy of Voyageur Pharmaceuticals and determine expected loss or profit from investing in Voyageur Pharmaceuticals over a given investment horizon. Check out Voyageur Pharmaceuticals Correlation, Voyageur Pharmaceuticals Volatility and Voyageur Pharmaceuticals Alpha and Beta module to complement your research on Voyageur Pharmaceuticals.
Please note, there is a significant difference between Voyageur Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Voyageur Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Voyageur Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Voyageur Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Voyageur Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Voyageur Pharmaceuticals.
0.00
11/27/2025
No Change 0.00
0.0
In 30 days
12/27/2025
0.00
If you would invest 0.00 in Voyageur Pharmaceuticals on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Voyageur Pharmaceuticals or generate 0.0% return on investment in Voyageur Pharmaceuticals over 30 days. Voyageur Pharmaceuticals is related to or competes with Avicanna, Charlottes Web, Raphael Pharmaceutical, Izotropic, and Rubicon Organics. Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals More
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Voyageur Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Voyageur Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Voyageur Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Voyageur Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Voyageur Pharmaceuticals historical prices to predict the future Voyageur Pharmaceuticals' volatility.
Voyageur Pharmaceuticals is out of control given 3 months investment horizon. Voyageur Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.11, which indicates the firm had a 0.11 % return per unit of risk over the last 3 months. We were able to interpolate data for seventeen different technical indicators, which can help you to evaluate if expected returns of 14.07% are justified by taking the suggested risk. Use Voyageur Pharmaceuticals Coefficient Of Variation of 831.78, risk adjusted performance of 0.0946, and Variance of 130354.71 to evaluate company specific risk that cannot be diversified away. Voyageur Pharmaceuticals holds a performance score of 8 on a scale of zero to a hundred. The entity has a beta of -79.69, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Voyageur Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Voyageur Pharmaceuticals is expected to outperform it. Use Voyageur Pharmaceuticals market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and kurtosis , to analyze future returns on Voyageur Pharmaceuticals.
Auto-correlation
1.00
Perfect predictability
Voyageur Pharmaceuticals has perfect predictability. Overlapping area represents the amount of predictability between Voyageur Pharmaceuticals time series from 27th of November 2025 to 12th of December 2025 and 12th of December 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Voyageur Pharmaceuticals price movement. The serial correlation of 1.0 indicates that 100.0% of current Voyageur Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
1.0
Spearman Rank Test
1.0
Residual Average
0.0
Price Variance
0.0
Voyageur Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Voyageur Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Voyageur Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Voyageur Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Voyageur Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Voyageur Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Voyageur Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Voyageur Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Voyageur Pharmaceuticals pink sheet over time.
Current vs Lagged Prices
Timeline
Voyageur Pharmaceuticals Lagged Returns
When evaluating Voyageur Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Voyageur Pharmaceuticals pink sheet have on its future price. Voyageur Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Voyageur Pharmaceuticals autocorrelation shows the relationship between Voyageur Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Voyageur Pharmaceuticals.
Other Information on Investing in Voyageur Pink Sheet
Voyageur Pharmaceuticals financial ratios help investors to determine whether Voyageur Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Voyageur with respect to the benefits of owning Voyageur Pharmaceuticals security.